Literature DB >> 26321465

Percutaneous correction of second toe proximal deformity: Proximal interphalangeal release, flexor digitorum brevis tenotomy and proximal phalanx osteotomy.

S Frey1, M Hélix-Giordanino2, B Piclet-Legré2.   

Abstract

We report the results of a percutaneous technique to correct a proximal plantar flexion deformity of the second toe that combines several procedures: tenotomy of the Flexor Digitorum Brevis, plantar capsulotomy for release of the proximal interphalangeal joint and proximal phalangeal osteotomy. The goal of these procedures is to improve anatomical correction and preserve articular range of motion. From 2009 to 2011, 54 patients, mean age 64.4 years old (43-81) underwent surgery for a proximal deformity of the second toe. Associated tenotomy of the extensor digitorum longus and brevis was performed in the presence of an extension deformity of the metatarsophalangeal joint (24 cases). After a mean follow-up of 30.7 ± 8.9 months, the rate of satisfaction and morphological correction was high (89.5% in both cases), as well as the number of flexible toes (88%). Active plantar flexion was preserved in 86% of the cases. This seems to be an effective technique to correct proximal plantar flexion deformity of the second toe, while preserving active plantar flexion.
Copyright © 2015. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Claw toe; Elective tenotomy; Hammer toe; Percutaneous surgery; Proximal interphalangeal osteotomy

Mesh:

Year:  2015        PMID: 26321465     DOI: 10.1016/j.otsr.2015.06.009

Source DB:  PubMed          Journal:  Orthop Traumatol Surg Res        ISSN: 1877-0568            Impact factor:   2.256


  1 in total

1.  Impact of intertendinous connections between the flexor digitorum brevis and longus on percutaneous tenotomy for the treatment of claw toes: an anatomic and ultrasound study.

Authors:  Julien Beldame; Matthieu Lalevée; Sixtine Regnard; Florent Marguet; Marie Csanyi-Bastien; Marion Masse; Fabrice Duparc
Journal:  Surg Radiol Anat       Date:  2021-03-04       Impact factor: 1.246

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.